NovaBay Pharmaceuticals Inc (NBY)
NBY on American Stock Exchange
1.34USD
19 Jun 2013
1.34USD
19 Jun 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.34
$1.34
Open
$1.34
$1.34
Day's High
$1.34
$1.34
Day's Low
$1.30
$1.30
Volume
25,400
25,400
Avg. Vol
188,271
188,271
52-wk High
$1.76
$1.76
52-wk Low
$1.05
$1.05
About
NovaBay Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on addressing the unmet therapeutic needs of the global anti-infective market. The Company’s Aganocide compounds, led by NVC-422, are patented, synthetic molecules with a spectrum of activity against bacteria, viruses and fungi. The Company is... (more)
Overall
| Beta: | 0.85 |
| Market Cap (Mil.): | $50.02 |
| Shares Outstanding (Mil.): | 37.33 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| NBY | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 40.13 | 30.65 |
| EPS (TTM): | -0.26 | -- | -- |
| ROI: | -70.73 | 2.36 | 18.83 |
| ROE: | -96.07 | 3.58 | 19.74 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.10 | -0.30 |
| Johnson & Johnson (JNJ.N) | $84.86 | -1.50 |
| Novartis AG (NOVN.VX) | CHF67.15 | 0.00 |
| Abbott Laboratories (ABT.N) | $36.21 | -1.30 |
| Sanofi SA (SASY.PA) | €80.79 | -0.76 |
| GlaxoSmithKline plc (GSK.L) | 1,665.00p | -11.00 |
| Smith & Nephew plc (SN.L) | 763.00p | -3.00 |
| PuriCore plc (PURI.L) | 39.00p | -1.50 |
| Oculus Innovative Sciences, Inc. (OCLS.OQ) | $2.88 | -0.13 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: TheStreet.com Ratings
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

